Is anti-cyclic citrullinated Peptide antibody a good value biomarker for Alzheimer disease?

Alzheimer's disease (AD) is one of the most important neurodegenerative disorder. Anti-cyclic citrullinated peptide (anti-CCP) may all be involved in the development of vascular disease such as AD. The aim of this study is detection of seropositivity for anti-CCP antibody in AD patients. In our...

Full description

Saved in:
Bibliographic Details
Published in:International journal of preventive medicine 2013-05, Vol.4 (Suppl 2), p.S201-S204
Main Authors: Meamar, Rokhsareh, Askari, Gholamreza, Ghasemi, Majid, Ghazvini, Mohammad Reza Aghaye, Vesal, Sahar, Sharifkhah, Mostafa, Faradonbeh, Nazanin Alaei, Dehghani, Leila
Format: Article
Language:English
Subjects:
Alzheimer's disease
anti-cyclic citrullinated peptide
Biomarkers
Brain research
Citrulline
Dementia
Health risk assessment
Homocysteine
Immunoassay
Immunoglobulins
Medical research
Metabolism
Multiple sclerosis
Neurodegeneration
Neurosciences
Original
Pathogenesis
Peptides
Proteins
Research centers
Rheumatoid arthritis
Rheumatology
Spectrophotometry
Studies
Tumor necrosis factor-TNF
Vascular diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alzheimer's disease (AD) is one of the most important neurodegenerative disorder. Anti-cyclic citrullinated peptide (anti-CCP) may all be involved in the development of vascular disease such as AD. The aim of this study is detection of seropositivity for anti-CCP antibody in AD patients. In our study, 30 patients with AD and 29 healthy controls (age and-sex matched) were recruited. Homocysteine and anti-CCP was measured by spectrophotometrically and immunoassay. Mean ± SE anti-CCP was higher significantly between AD (13.6 ± 3) and healthy subjects (4.8 ± 0.2) (P = 0.006). In the patients, anti-CCP serum level was in high range (32.1%) of abnormal levels, but there was no significant difference in serum homocysteine in AD patients compared with controls. There is no correlation between anti-CCP and homocysteine levels in AD patients (P = 0.75), but between age and anti-CCP level observed a significantly correlation (P = 0.04). It needs more studies to clarify confirmation the role of anti-CCP antibody production in AD patients.
ISSN:2008-7802
2008-8213